NASDAQ:GEHC GE HealthCare Technologies Q3 2025 Earnings Report $76.76 -0.07 (-0.08%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast GE HealthCare Technologies EPS ResultsActual EPSN/AConsensus EPS $1.05Beat/MissN/AOne Year Ago EPSN/AGE HealthCare Technologies Revenue ResultsActual RevenueN/AExpected Revenue$5.07 billionBeat/MissN/AYoY Revenue GrowthN/AGE HealthCare Technologies Announcement DetailsQuarterQ3 2025Date10/29/2025TimeBefore Market OpensConference Call DateWednesday, October 29, 2025Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile GE HealthCare Technologies Earnings HeadlinesCan GE HealthCare's (GEHC) AI Software Push Reveal Its Long-Term Position in Oncology Innovation?4 hours ago | finance.yahoo.comGE HealthCare to announce third quarter 2025 results on October 29, 2025October 1 at 8:30 AM | businesswire.comRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fund firm manager who predicted 2008 and 2020 just issued. He says if you're over 50, there's one urgent move you need to make to survive... or risk getting left behind.October 3 at 2:00 AM | Stansberry Research (Ad)GE HealthCare: A Global Medical Equipment Leader Facing Tighter Margins LatelySeptember 29, 2025 | seekingalpha.comGE HealthCare Technologies declares $0.035 dividendSeptember 24, 2025 | msn.comGE HealthCare announces cash dividend for third quarter of 2025September 24, 2025 | businesswire.comSee More GE HealthCare Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like GE HealthCare Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GE HealthCare Technologies and other key companies, straight to your email. Email Address About GE HealthCare TechnologiesGE HealthCare Technologies (NASDAQ:GEHC), Inc. (NASDAQ: GEHC) is a global medical technology and life sciences company that develops and delivers diagnostic imaging, radiotherapy, digital solutions and biopharmaceutical manufacturing technologies. Its product portfolio includes advanced magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, molecular imaging and X-ray systems, along with interventional and surgical imaging equipment designed to enhance diagnostic accuracy and patient care. Beyond hardware, GE HealthCare provides software platforms that enable clinical data management, workflow optimization, artificial intelligence–driven analytics and remote patient monitoring. Its life sciences division supplies single-use technologies, cell therapy tools and customized processing systems for biopharmaceutical research, development and manufacturing, supporting pharmaceutical customers in bringing therapies from concept to commercialization. Headquartered in Chicago, Illinois, GE HealthCare serves healthcare providers, research institutions and pharmaceutical companies in more than 160 countries through a combination of direct sales, service operations and channel partners. The business traces its origins to the early days of commercial X-ray and evolved as part of General Electric’s Healthcare division before becoming an independent public company in early 2023. Under the leadership of CEO Peter Arduini, the company continues to expand its global footprint and invest in innovation to address evolving healthcare challenges.View GE HealthCare Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings Upcoming Earnings PepsiCo (10/9/2025)Fastenal (10/13/2025)BlackRock (10/14/2025)Citigroup (10/14/2025)The Goldman Sachs Group (10/14/2025)Johnson & Johnson (10/14/2025)JPMorgan Chase & Co. (10/14/2025)Wells Fargo & Company (10/14/2025)ASML (10/15/2025)Abbott Laboratories (10/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
